SCHEMBL2603465

SCHEMBL2603465

CCCCOC(=O)C1(C)CCCC2(C)c3cc(Oc4cc5c(cc4C(C)C)CCC4C(C)(C(=O)OC)CCCC54C)c(C(C)C)cc3CCC12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD16A O95870 2/20 0.55
POLA1 P09884 4/20 0.55
SOD1 P00441 1/20 0.52
NR1H2 P55055 7/20 0.51
NR1H3 Q13133 7/20 0.51
NR1I2 O75469 1/20 0.49
OPRK1 P41145 1/20 0.49
CYP3A4 P08684 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RXRA P19793 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2603463 0.91 ABHD16A (0.63) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL2603469 0.90 ABHD16A (0.55) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL2603467 0.89 ABHD16A (0.57) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL14299768 0.87 ABHD16A (0.56) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL14299770 0.85 ABHD16A (0.55) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL2603451 0.81 NR1H2 (0.71) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL2603436 0.81 ABHD16A (0.61) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL2603454 0.81 NR1I2 (0.71) ABHD16APOLA1NR1H2NR1H3NR1I2
SCHEMBL15342888 0.81 ABHD16A (0.75) ABHD16APOLA1SOD1NR1H2NR1H3
SCHEMBL15339327 0.81 NR1H2 (0.56) ABHD16APOLA1SOD1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101250-A1 NOVEL DEHYDROABIETIC ACID POLYMER FUJIFILM CORPORATION (JP) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101250-A1 NOVEL DEHYDROABIETIC ACID POLYMER DPAGT1, DDOST, ALAD ABHD16A 73/4885POLA1 1710/4885SOD1 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.